Guidelines Updated for Idiopathic Pulmonary Fibrosis Treatment
Panel strongly against use of anticoagulation, imatinib, endothelin receptor antagonist
Arts Observation Curriculum May Be Beneficial for Medical Students
Learning to observe objectively and communicate observations important in clinical practice
Progress in Reporting Conflict of Interest Among IRB Members
Percentage of members who felt another member didn't disclose financial relationships down '05 to '14
Second Severe Allergic Reaction Within Hours Isn’t Uncommon
Researchers find about one in seven children have repeat episode
Strategies Needed to Combat Weight Gain in Smoking Cessation
Considerably greater weight gain seen in North American versus Asian studies
Structured Exercise Prevents Sleep Issues in Older Adults
However, physical activity intervention not found to resolve existing sleep issues
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
Weekend Discharge Not Linked to Increased Readmission
Findings among patients with AMI, congestive heart failure, pneumonia in California
Farm-Related Immunoregulation Tied to Dendritic Cell Subset
Lower levels of circulating myeloid dendritic cell subtype 2 in children who live on farms
Low FEV1 in Early Adulthood May Be Important in COPD Genesis
While accelerated decline in FEV1 is not an obligate feature of COPD
